According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

New analyses show Johnson & Johnson’s one-dose vaccine works well.

A research team at BIDMC led by James E. Kirby, MD (Clinical Microbiology, BIDMC) and Ramy Arnaout, MD (Clinical Microbiology, BIDMC) has developed a mathematical model to estimate the false negative rate for COVID-19 tests.

Beth Israel Deaconess researchers build tool to estimate false negative COVID-19 test rates

BIDMC researchers build tool to estimate false negative COVID-19 test rates

A research team at BIDMC led by James E. Kirby...

Advisers are set the meet this week to discuss the recommendation of the Johnson & Johnson one-shot vaccine for emergency use authorization. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) noted the process needs to be accelerated for vaccine rollout in the United States and throughout the world.

Local doctor who assisted in development of J&J vaccine says having another option is critical

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) noted that the urgency of the COVID-19 pandemic, combined with advances in funding and technology, enabled the vaccine to be a global effort.

How to have a conversation with someone who’s hesitant about the Covid vaccine

Kevin P. Hill, MD (Addiction Psychiatry, BIDMC) shared how people with substance use disorder have been hit especially hard by the COVID-19 pandemic and what the Division of Addiction Psychiatry at BIDMC is doing to address this problem.

The stress and worry that came with the pandemic have proved to be a stern test of the coping strategies for those with substance use disorder.

Sharon Wright, MD, MPH (Infectious Disease, BIDMC) speaks about the latest COVID-19 headlines, including the pace of the vaccine rollout, what the FDA Advisory Committee takes into consideration as they consider a vaccine candidate for emergency use authorization, whether COVID-19 could be a season virus, as well as the sobering milestone of 500,000 lives lost during this pandemic.

Mass. doctor on COVID-19 case, hospitalization drop

As the pandemic stretches toward the one-year mark, with about half a million deaths in the U.S. alone, some healthcare workers are staying creative to cope with stress or to share a message of hope with their community. During the pandemic, Michael Gibson, MD (Interventional Cardiology, BIDMC) created about ten paintings, including one painting that was auctioned off to support healthcare workers.

Healthcare workers are turning to art to cope. Here are some of their projects

As Massachusetts and several other states prioritize vaccine distribution to residents with cancer, heart disease, obesity and other medical concerns, many are still trying to figure out if they qualify as criteria with these diseases remain unclear. Sean Levy, MD (Pulmonary Disease, BIDMC) noted some eligible risk factors like smoking are open to interpretation.

Do I Qualify? Vaccine Confusion For Patients With Multiple Serious Medical Conditions